Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NGM Biopharmaceuticals In...

    NASDAQ: NGM · Real-Time Price · USD
    1.54
    -0.02 (-1.28%)
    At close: Apr 03, 2024, 3:59 PM

    NGM Biopharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 58.81M 73.46M 151.79M
    Short-Term Investments
    		 88.37M 198.04M 214.46M
    Long-Term Investments
    		 2.46M 3.95M 1.5M
    Other Long-Term Assets
    		 2.94M 4M 7.49M
    Receivables
    		 58K 7.58M 4.95M
    Inventory
    		 n/a n/a n/a
    Other Current Assets
    		 9.2M 9.79M 8.08M
    Total Current Assets
    		 156.44M 288.86M 379.28M
    Property-Plant & Equipment
    		 7.03M 10.59M 14.12M
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 12.42M 18.54M 23.11M
    Total Assets
    		 168.87M 307.4M 402.39M
    Account Payables
    		 2.98M 8.45M 5.25M
    Deferred Revenue
    		 n/a 366K 17.77M
    Short-Term Debt
    		 n/a 5.38M 5.08M
    Other Current Liabilities
    		 17.1M 33.64M 33.26M
    Total Current Liabilities
    		 20.08M 47.84M 61.35M
    Long-Term Debt
    		 n/a n/a 5.38M
    Other Long-Term Liabilities
    		 149K n/a n/a
    Total Long-Term Liabilities
    		 149K 14.2M 5.38M
    Total Liabilities
    		 20.23M 47.84M 66.74M
    Total Debt
    		 n/a 5.38M 10.46M
    Common Stock
    		 83K 82K 78K
    Retained Earnings
    		 -724.01M -581.63M -418.97M
    Comprehensive Income
    		 18K -302K -129K
    Shareholders Equity
    		 148.64M 259.56M 335.65M
    Total Investments
    		 90.82M 198.04M 214.46M

    Add to Watchlist